ENO2 and gastric adenocarcinoma: The median levels of serum NSE, CEA, CA19-9, CA242 in patients with gastric adenocarcinoma were 20.770, 2.700 ng/mL, 11.840, 6.050 U/mL respectively, comparing with 15.625, 1.765 ng/mL, 9.535, 3.740 U/mL in healthy controls.